Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
Version 2 2024-03-12, 12:08Version 2 2024-03-12, 12:08
Version 1 2024-03-01, 08:33Version 1 2024-03-01, 08:33
journal contribution
posted on 2024-03-12, 12:08 authored by Thida Win, Benjamin A. Thomas, Pauline Lukey, Peter J. Ell, Ashley M. Groves, Tryphon Lambrou, Brian F. Hutton, Nicholas J. Screaton, Joanna C. Porter, Toby M. Maher, Raymondo Endozo, Robert I. Shortman, Asim Afaq<p>Purpose: Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morphological abnormality on high-resolution computed tomography (HRCT). The purpose of this investigation was to investigate the PET signal at sites of normal-appearing lung on HRCT in IPF. Methods: Consecutive IPF patients (22 men, 3 women) were prospectively recruited. The patients underwent 18F-FDG PET/HRCT. The pulmonary imaging findings in the IPF patients were compared to the findings in a control population. Pulmonary uptake of 18F-FDG (mean SUV) was quantified at sites of morphologically normal parenchyma on HRCT. SUVs were also corrected for tissue fraction (TF). The mean SUV in IPF patients was compared with that in 25 controls (patients with lymphoma in remission or suspected paraneoplastic syndrome with normal PET/CT appearances). Results: The pulmonary SUV (mean ± SD) uncorrected for TF in the controls was 0.48 ± 0.14 and 0.78 ± 0.24 taken from normal lung regions in IPF patients (p < 0.001). The TF-corrected mean SUV in the controls was 2.24 ± 0.29 and 3.24 ± 0.84 in IPF patients (p < 0.001). Conclusion: IPF patients have increased pulmonary uptake of 18F-FDG on PET in areas of lung with a normal morphological appearance on HRCT. This may have implications for determining disease mechanisms and treatment monitoring. © 2013 The Author(s).</p>
History
School affiliated with
- School of Computer Science (Research Outputs)
Publication Title
European Journal of Nuclear Medicine and Molecular ImagingVolume
41Issue
2Pages/Article Number
337-342Publisher
Springer Verlag (Germany) for: European Association of Nuclear MedicineExternal DOI
ISSN
1619-7070eISSN
1619-7089Date Submitted
2013-08-30Date Accepted
2013-07-07Date of First Publication
2013-08-14Date of Final Publication
2014-02-01Date Document First Uploaded
2015-11-27ePrints ID
11747Usage metrics
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC


